<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/7253</identifier>
				<datestamp>2020-10-16T01:02:03Z</datestamp>
				<setSpec>aabp:RS</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Effects of the administration of a bovine non-specific immune stimulant around transportation on health and performance of Jersey and Jerseycross heifer calves in the first 60 days of life</dc:title>
	<dc:creator xml:lang="en">Omontese, B. O.</dc:creator>
	<dc:creator xml:lang="en">Celestino, M. L.</dc:creator>
	<dc:creator xml:lang="en">Paiva, D.</dc:creator>
	<dc:creator xml:lang="en">Menta, P.</dc:creator>
	<dc:creator xml:lang="en">Garcia-Munoz, A.</dc:creator>
	<dc:creator xml:lang="en">Masic, A.</dc:creator>
	<dc:creator xml:lang="en">Machado, V. S.</dc:creator>
	<dc:creator xml:lang="en">Caixeta, L. S.</dc:creator>
	<dc:subject xml:lang="en">pre-weaned dairy calves</dc:subject>
	<dc:subject xml:lang="en">diarrhea</dc:subject>
	<dc:subject xml:lang="en">pneumonia</dc:subject>
	<dc:subject xml:lang="en">non-specific immune stimulant</dc:subject>
	<dc:subject xml:lang="en">transportation</dc:subject>
	<dc:description xml:lang="en">Health and performance of pre-weaned dairy calves have great influence on adult life performance. Amongst the diseases that affect young dairy calves, diarrhea and pneumonia are the most prevalent and economically important. The main objective of this study was to evaluate the effects of a non-specific immune stimulant (IS; Amplimune, NovaVive, Inc., Canada), administered around transportation, on the health and performance of Jersey and Jersey-cross heifer calves during the first 60 days of life. We hypothesized that calves receiving IS would have decreased disease treatment hazard, lower weekly health scores (HS), decreased mortality, and superior performance.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2019-09-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/7253</dc:identifier>
	<dc:identifier>10.21423/aabppro20197253</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 2019; 366</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/7253/5996</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2019 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
